Skip to content 
“From when I started at Helix,” I said. “They offered me one hundred eighty thousand to leave my postdoc and join as a senior researcher. I accepted and used all of it to reduce the mortgage.”
Brooke’s smile had gone stiff, slipping at the edges.
“You got a hundred eighty thousand dollars just for signing?” she asked, her voice thin.
“That’s common for senior pharmaceutical research roles,” I explained. “Especially in specialized oncology work. My current annual compensation is about three hundred seventy-five thousand, including bonuses and stock options.”
Somewhere nearby, a glass slipped and shattered against the marble floor. Several guests turned.
“Three hundred seventy-five,” my father repeated mechanically. “A year?”
“Base is two eighty,” I clarified. “Performance bonuses average around sixty, and my stock options vested this year at about thirty-five.”
James raised his glass slightly toward me. “She’s being modest. She also has around four hundred twenty thousand in unvested equity. And then there are the patent royalties.”
“Patent royalties?” my mother whispered, her fingers white around the stem of her glass.
“I hold eleven patents in oncology drug delivery systems,” I said. “They bring in about ninety-five thousand a year in licensing fees.”
Brooke’s raised hand began to tremble. Suddenly, her diamond didn’t seem quite as large.
I watched my parents’ faces. They were seeing me, maybe for the first time, as someone who did not fit the faint, disappointing outline they had created years ago and never bothered to update.
“I don’t understand,” my mother said, her voice breaking. “You’re a pharmaceutical researcher. How can you afford all of this?”
“I’m the director of oncology research at Helix Pharmaceuticals,” I corrected gently. “I oversee forty-seven researchers. We’re currently in phase three trials for a drug that could greatly improve pancreatic cancer treatment.”
“Director,” my father repeated slowly.
James pulled out his phone and scrolled. “Actually, Sophia’s work was featured in Nature Medicine last month. The article called her research groundbreaking and potentially Nobel-worthy. I forwarded it to you, Patricia. Did you not see it?”
My father made a small choking sound.
“Nobel Prize?” he said hoarsely. “They’re talking about Nobel Prizes?”
“It’s too early for that,” I said, uncomfortable. “But the research is promising. If phase three succeeds, it could save thousands of lives each year.”
Brooke’s voice cut through the silence, sharp and brittle.
“Why didn’t you tell us any of this?” she demanded. “You never told us you bought a house. Or made that kind of money. Or any of this.”
I looked at her.
“I did tell you,” I said quietly. “More than once.”
“That’s not true,” my father protested instantly. “We would remember something like this.”
James looked up from his phone, his expression becoming serious.
“Actually, it is true,” he said. “I have the emails Sophia sent me. November 2016—she told you both about the house. You told her she was being financially irresponsible and that the market might crash. Patricia, you asked whether she was sure she could handle the maintenance. I remember because it irritated me.”
My mother flushed.
“I was only worried about you,” she said defensively. “Buying a house is a major responsibility.”
“April 2018,” James continued. “Sophia mentioned at Easter dinner that she had paid off the mortgage. You asked if that meant she was unemployed. That was the exact word.”
“We didn’t say that,” my mother protested weakly.
“You did,” I said quietly. “You assumed paying off a mortgage meant I had lost my job, not that I had succeeded enough to eliminate the debt.”
The distinction seemed to hurt her. Tears filled her eyes. My father clenched his jaw until the muscle jumped.
James shifted the subject, but only slightly.
“Sophia,” he said casually, “have you decided about the lake house investment yet? That property was stunning. I haven’t stopped thinking about it.”
My parents turned toward him at the same time.
“What lake house?” my father demanded.
“There’s a luxury property on Lake Serenity,” James explained. “Six bedrooms, private dock, three acres. Strong short-term rental potential. Sophia is considering buying it as a vacation rental.”
Brooke stared at him, then me, her face pale.
“Why would Sophia buy a vacation rental?” she asked. “She doesn’t even take vacations.”
“For income diversification,” James replied. “She already owns four rental properties besides her main home. This would be her sixth property overall.”
If the earlier numbers had landed like stones, this one hit like thunder.
My mother swayed slightly. My father reached out to steady her. Brooke looked like someone had taken the script from her hands and rewritten it in a language she couldn’t read.
“Four rental properties,” my mother whispered. “You own four?”
“Small single-family homes in growing neighborhoods,” I said. “I buy below market value, renovate, and rent them to young professionals. Average cash flow is about eighteen hundred per unit after expenses.”
My father’s eyes narrowed as his mind grabbed onto the math.
“That’s seventy-two hundred a month,” he said slowly. “Over eighty-six thousand a year. Plus appreciation.”
James nodded. “Those properties have gone up by an average of forty-two percent since she bought them. Her real estate equity is about two-point-one million.”
My parents stared at him.
“Two million,” my father said.
“That’s only real estate,” James corrected. “Sophia’s total net worth is closer to three-point-two million when you include retirement, investments, stock options, liquid assets…”
“Three million?” Brooke’s voice cracked.
“About three-point-two,” I said quietly. “Though market changes can affect the exact number.”
My mother’s champagne flute slipped from her hand and shattered against the marble.
“You’re a multi-millionaire?” she asked, the word sounding strange in her mouth.
“On paper,” I said. “Most of it is invested or tied up in property.”
Before they could respond, Dr. Elizabeth Park approached, smiling when she saw me.
“Sophia,” she said warmly. “I didn’t know you were here. Congratulations on the FDA breakthrough designation. That’s incredible.”
My mother turned sharply. “The what?”
“Thank you, Elizabeth,” I said. Her presence felt like a bridge back to my real life. “We’re excited. It still feels a little unreal.”
My father looked confused. “FDA what?”
“The FDA granted our pancreatic cancer drug breakthrough therapy designation three weeks ago,” I explained. “It speeds up the approval process. If things go well, approval could happen in eighteen months instead of four years.”
Elizabeth smiled at my parents, assuming they would be proud. “Sophia’s work is going to save countless lives. She’s brilliant. Are you going to the Geneva conference next month? I heard you’re presenting.”
“I’m presenting preliminary phase three data,” I said. “And giving the keynote on novel drug delivery mechanisms.”
“The keynote?” my mother repeated faintly.
“The international oncology research symposium,” I said. “It’s one of the major conferences in the field. I’m giving the keynote this year. It’s a significant honor.”
James scoffed lightly. “Significant? She’s the youngest keynote speaker in the symposium’s forty-year history.”
Brooke stared at me like I had become a stranger.
“So you’re famous now?” she asked. “Some kind of science celebrity?”
“I’m not famous,” I said. “I’m respected in my field. There’s a difference.”
“She’s published thirty-seven peer-reviewed papers,” Elizabeth added. “Her research has been cited over four thousand times. She has changed oncology drug delivery. That is recognition of real brilliance.”
My parents looked stunned. Brooke looked like she might be sick.